Kaufman DS - Search Results

1

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy.

Smith MR, Manola J, Kaufman DS, George D, Oh WK, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff PW. Smith MR, et al. Among authors: kaufman ds. Cancer. 2004 Oct 1;101(7):1569-74. doi: 10.1002/cncr.20493. Cancer. 2004. PMID: 15468186 Free article. Clinical Trial.

2

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.

Smith MR, Kaufman D, George D, Oh WK, Kazanis M, Manola J, Kantoff PW. Smith MR, et al. Cancer. 2002 Nov 1;95(9):1864-8. doi: 10.1002/cncr.10844. Cancer. 2002. PMID: 12404279 Free article. Clinical Trial.

3

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.

Oh WK, Manola J, Bittmann L, Brufsky A, Kaplan ID, Smith MR, Kaufman DS, Kantoff PW. Oh WK, et al. Among authors: kaufman ds. Urology. 2003 Jul;62(1):99-104. doi: 10.1016/s0090-4295(03)00145-6. Urology. 2003. PMID: 12837431 Clinical Trial.

4

A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer.

Oh WK, Hagmann E, Manola J, George DJ, Gilligan TD, Jacobson JO, Smith MR, Kaufman DS, Kantoff PW. Oh WK, et al. Among authors: kaufman ds. Clin Cancer Res. 2005 Jan 1;11(1):284-9. Clin Cancer Res. 2005. PMID: 15671557 Clinical Trial.

5

Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy.

Smith MR, Manola J, Kaufman DS, Oh WK, Bubley GJ, Kantoff PW. Smith MR, et al. Among authors: kaufman ds. J Clin Oncol. 2006 Jun 20;24(18):2723-8. doi: 10.1200/JCO.2005.03.7804. J Clin Oncol. 2006. PMID: 16782912 Clinical Trial.

6

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.

Michaelson MD, Kaufman DS, Kantoff P, Oh WK, Smith MR. Michaelson MD, et al. Among authors: kaufman ds. Cancer. 2006 Aug 1;107(3):530-5. doi: 10.1002/cncr.22043. Cancer. 2006. PMID: 16804927 Free article. Clinical Trial.

7

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study.

Smith MR, Kaufman D, Oh W, Guerin K, Seiden M, Makatsoris T, Manola J, Kantoff PW. Smith MR, et al. Cancer. 2000 Oct 15;89(8):1824-8. doi: 10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r. Cancer. 2000. PMID: 11042579 Clinical Trial.

8

A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients.

Oh WK, Manola J, George DJ, Fierman A, Fontaine-Rothe P, Morrissey S, Prisby J, Kaufman DS, Shapiro CL, Kantoff PW, Smith MR. Oh WK, et al. Among authors: kaufman ds. Cancer Invest. 2002;20(2):186-91. doi: 10.1081/cnv-120001145. Cancer Invest. 2002. PMID: 11901538 Clinical Trial.

9

Male patients with diagnoses of both breast cancer and prostate cancer.

Leibowitz SB, Garber JE, Fox EA, Loda M, Kaufman DS, Kantoff PW, Oh WK. Leibowitz SB, et al. Among authors: kaufman ds. Breast J. 2003 May-Jun;9(3):208-12. doi: 10.1046/j.1524-4741.2003.09312.x. Breast J. 2003. PMID: 12752629

10

Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity.

Oh WK, Kaplan ID, Febbo P, Prisby J, Manola J, Kaufman DS, Kantoff PW. Oh WK, et al. Among authors: kaufman ds. Am J Clin Oncol. 2003 Jun;26(3):312-6. doi: 10.1097/01.COC.0000020921.08768.1F. Am J Clin Oncol. 2003. PMID: 12796607 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters